YOCHAI BIRNBAUM to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications YOCHAI BIRNBAUM has written about Platelet Aggregation Inhibitors.
Connection Strength
2.372
-
Ticagrelor Improves Remodeling, Reduces Apoptosis, Inflammation and Fibrosis and Increases the Number of Progenitor Stem Cells After Myocardial Infarction in a Rat Model of Ischemia Reperfusion. Cell Physiol Biochem. 2019; 53(6):961-981.
Score: 0.501
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.500
-
Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions. Ann N Y Acad Sci. 2010 Oct; 1207:76-82.
Score: 0.283
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
Score: 0.186
-
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Cardiovasc Drugs Ther. 2024 Jun; 38(3):605-619.
Score: 0.160
-
Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers. Cardiovasc Drugs Ther. 2024 Feb; 38(1):181-189.
Score: 0.159
-
Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention. Am J Cardiol. 2022 07 01; 174:182-184.
Score: 0.158
-
Cilostazol: a Review of Basic Mechanisms and Clinical Uses. Cardiovasc Drugs Ther. 2022 08; 36(4):777-792.
Score: 0.147
-
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine. Cardiovasc Drugs Ther. 2016 Dec; 30(6):539-550.
Score: 0.109
-
Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv. 2008 Oct 01; 72(4):488-97.
Score: 0.062
-
Dual Anti-platelet Therapy After Transcatheter Aortic Valve Implantation: Double Trouble? Cardiovasc Drugs Ther. 2022 12; 36(6):1239-1241.
Score: 0.038
-
Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis. 2001 May; 11(3):223-8.
Score: 0.037
-
Circulating blood cells and extracellular vesicles in acute cardioprotection. Cardiovasc Res. 2019 06 01; 115(7):1156-1166.
Score: 0.032